All cells within the same cancer are not the same. They all have genetic errors that turn them into tumor cells, but these errors are not identical. In each cancer, there are populations of cells with ...

A clonal competition assay showing populations of cells with different mutations. Depending on the mutation, each population of cells is stained a different colour. The new tool detects the ...

The early identification of antibody candidates with desired affinities and dissociation kinetics, binding epitopes and critical quality attributes is vital for avoiding later-phase failures caused by ...

Examine how large-scale screening of AI-designed binders informs CAR T-cell engineering and functional validation.

This article is based on a poster originally authored by James Craswell, Holly Madden, Thomas Peplow, Tayo Alleyne-Weir, Eleftheria Arvaniti, William Lee, Soumya Dhanavade, Jim Reid, Phil Leonard, ...

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays. Researchers from Uniquity Bio and Mosaic Biosciences conducted head-to-head in ...

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...

Engagement of intracellular targets is often critical to drug mechanisms. Establishing a target engagement (TE) profile is an important step in small- molecule drug discovery as well as chemical probe ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.